Advertisement

Topics

Companies Related to "Use of the GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions of Saphenous Vein Graft" [Most Relevant Company Matches] RSS

01:54 EDT 22nd October 2018 | BioPortfolio

Here are the most relevant search results for "Use of the GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions of Saphenous Vein Graft" found in our extensive corporate database of over 50,000 company records.

Showing "GARDEX trade Embolic Protection Device During Percutaneous Coronary" Companies 1–25 of 2,700+

Extremely Relevant

InspireMD

InspireMD Ltd. is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The company intends to apply its technology to develop products used in interventional cardiology and other vascular procedures. InspireMD's mission is to utilize its proprietary technology to make its products the industry standard fo...


Inspire MD

InspireMD is an innovative medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The company intends to apply its technology to develop products used in interventional cardiology and other vascular procedures. InspireMD's mission is to utilize its proprietary technology to make its products the industry standard for ste...

Relevant

Corindus Vascular Robotics

Corindus designs, manufactures and commercializes precision vascular robotic systems for use in minimally invasive procedures. The Company’s disposable medical device business model is enabled by a simple and low-cost console. The Company’s initial product, the CorPath™ system, is the world’s first to precisely drive coronary guidewires...


Ischemix

Ischemix is a privately-held drug discovery company with a portfolio of small molecule therapeutic compounds. The first of these compounds is targeted to reduce cell death and organ damage due to initial interruption and subsequent resumption of blood flow associated with cardiac surgeries and interventional procedures such as percutaneous coronary interve...

Kensey Nash

IntraLuminal Therapeutics, Inc. is a medical device company focused on both providing and developing products for the Interventional Cardiologist and Radiologist to cross and recanalize totally occluded arteries. The company was co-founded by Dr. Geoffrey Hartzler, pioneer of multi-vessel percutaneous transluminal coronary intervention (PTCI) and a recognized leader in the area of interventional c...

Corindus Vascular Robotics, Inc.

Corindus Vascular Robotics, Inc. (OTCQB: CVRS) is a global technology leader in robotic-assisted percutaneous coronary interventions (PCIs). The Company’s FDA-cleared CorPath 200 System is the first medical device that offers interventional cardiologists PCI procedure control from an interventional cockpit. With the CorPath System, Corindus Vascular R...

AgroConnect.com

Now, for the first time, professionals in the Crop Protection Industry around the world can instantly connect with ease, convenience and cost efficiency to an ever-expanding base of new contacts in the international arena with the launch of AgroConnect.com. AgroConnect is offering an extraordinary opportunity to companies seeking to aggressively secure a lucrative share in the arena of crop protec...

InfraReDx, Inc.

InfraReDx, Inc., headquartered in Burlington, Massachusetts, is a privately-funded medical device company founded in 1998 and focused on intravascular characterization of disease in the coronary arteries. InfraReDx is the maker of the LipiScan(TM) system, a novel near-infrared (NIR) spectroscopy catheter that can detect the lipid core coronary plaques suspected to cause most heart attacks and know...

Lombard Medical Technologies PLC

Lombard Medical Technologies PLC is a global medical technology company focussed on providing innovative endovascular products which broaden clinicians’ treatment options and opportunities for treating more patients safely and more efficiently with Endovascular Aortic Repair (EVAR). Aorfix™ endovascular stent graft, Lombard Medical Technologies flagship product, addresses previousl...

Medical Protection Technologies

Medical Protection Technologies, based in Friday Harbor, Wash., is the exclusive North American provider of medical device products made from the unique shock-absorbing material D3O®. Its initial product, the Fall-Safe® Hip Protector, offers the ideal combination of high impact protection and wearing comfort—even when sleeping—thereby enhan...

Cappella, Inc.

Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD), specifically bifurcation disease. Cappella’s initial product, the Sideguard® Coronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses on treating...

Cappella Inc.

Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. Cappella's initial product, the Sideguard® Coronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses on treating the sidebranch of diseased coronary ...

Embrella Cardiovascular, Inc.

Embrella Cardiovascular™, Inc., is dedicated to creating a new standard-of-care for cerebral embolic protection during cardiovascular procedures. Embrella's Embolic Deflector®, an aortic embolic protection device which acts as a protective shield to reduce the incidence of embolization to the brain, has been granted CE Mark approval. Embrella is a ...

Cappella Medical Devices Ltd

Cappella, Inc. is a medical device company that develops novel solutions for the treatment of complex coronary artery disease (CAD) focused on protecting the coronary sidebranch arteries. Cappella’s Sideguard® coronary sidebranch technology offers interventional cardiologists a straightforward, effective, and easy to use solution that preserves the ...

Surgica Corporation

Surgica Corporation manufactures and markets embolization medical devices for the rapidly growing minimally invasive surgical and therapeutic specialties. Embolization is a minimally invasive procedure that can reduce tumors and vascular malformations by closing off the blood vessels that feed them.The procedure is performed by an interventional radiologist, who advances a catheter through the vas...

Jacobacci & Partners

Jacobacci & Partners is the largest firm in Italy, and one of the most important in Europe, specialized in the legal protection and defence of intellectual property. Founded in 1872 in Turin, where at that time the Italian Patents and Trade-marks Office was located, Jacobacci & Partners has long been a leader in the protection of trademarks and patents thanks to the continuous development of its ...

CPC of America

We are engaged in the business of developing and/or acquiring cardiology therapeutic and disposable devices and products as well as the manufacturing and distributing of these devices and products for the diagnosis and treatment of coronary artery disease. To date, we have developed and/or acquired two products: the CPCA2000™ counterpulsation device and MedClose™, an internal puncture closing ...

SpineAlign Medical, Inc.

The SpineAlign device represents the first of many new innovations in the area of minimally invasive percutaneous vertebral body reconstruction and augmentation to be developed by SpineAlign Medical. The SpineAlign device is a vertebral body implant designed to treat fractures in the thoracic or lumbar spine in patients suffering from osteoporosis. The Spi...

PLC Systems

PLC is a global leader in the development of products for performing a revolutionary new surgical procedure known as transmyocardial revascularization (TMR). TMR offers a completely new medical treatment option for patients who suffer from severe coronary artery disease. Coronary artery disease is the leading cause of death in the United States. Working with leading researchers and premier heart...

PlaqueTec Ltd.

PlaqueTec offers a first-of-its-kind catheter technology for cardiologists to routinely assess inflammation in the coronary artery, and better understand residual inflammatory risk. It has been proven to detect inflammatory molecules across the site of coronary artery disease (CAD), and can discriminate between patients with greater and lesser levels of co...

Dr. Wieland GmbH & Co. KG

This saying determines our -everyday- way of doing trade. The HugoHäffner Group is known for being one of the pioneers regarding the protection of human and environment. Our aim is not only to respect regulations and laws but if possible to exceed their expectations.

Gardia Medical Ltd

Gardia Medical specializes in the development and commercialization of catheter-based delivery systems that easily integrate with the standard workflow of stenting and other cardiovascular interventional procedures. Its flagship product is the first and only CE marked embolic protection system to Deliver, Lock, and Deploy on any guide wire, anywhere on the wire. Its compatibility with standard...

Boult Wade Tennant

Boult Wade Tennant is a leading UK-based firm of European Patent and Trade Mark Attorneys and Chartered Patent Attorneys. We assist small, medium and large corporate entities and individuals to establish, protect, and exploit intellectual property rights in the UK, in the rest of Europe and worldwide. The firm is one of the larger patent and trade mark firms in the UK and has 16 partners, 30 other...

Cappella Medical Devices, Ltd.

Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. Cappella’s initial product, the Sideguard® Coronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses...

MicroVention, Inc.

The Company was founded in April 1997 by Robert Rosenbluth and Brian Cox and incorporated as MicroVention, Inc. in September. MicroVention established the strategic objective of developing and marketing medical devices, which will enable or significantly improve the treatment of diseases in small vessels. Joining the team in December of 1997, Rob Greene brought key neurovascular device experience....


More From BioPortfolio on "Use of the GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions of Saphenous Vein Graft"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks